| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 5.62B | 5.08B | 4.45B | 3.94B | 3.90B |
| Gross Profit | 604.20M | 569.70M | 499.90M | 407.30M | 422.90M |
| EBITDA | 315.10M | 269.70M | 249.70M | 205.00M | 137.50M |
| Net Income | 82.60M | 101.40M | 126.30M | 91.10M | 37.70M |
Balance Sheet | |||||
| Total Assets | 2.54B | 2.12B | 1.93B | 1.83B | 1.82B |
| Cash, Cash Equivalents and Short-Term Investments | 108.90M | 176.10M | 244.90M | 248.30M | 345.20M |
| Total Debt | 553.40M | 375.10M | 321.50M | 286.00M | 300.60M |
| Total Liabilities | 2.01B | 1.69B | 1.45B | 1.41B | 1.40B |
| Stockholders Equity | 514.30M | 410.40M | 453.20M | 421.70M | 425.80M |
Cash Flow | |||||
| Free Cash Flow | 215.70M | 188.40M | 177.80M | 69.00M | 198.90M |
| Operating Cash Flow | 249.10M | 220.00M | 197.70M | 94.20M | 234.50M |
| Investing Cash Flow | -273.70M | -77.90M | -41.70M | -35.70M | -30.20M |
| Financing Cash Flow | -47.20M | -206.30M | -158.90M | -156.40M | -55.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £2.25B | 16.00 | 16.69% | 1.27% | 1.69% | 276.44% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | £1.88B | 23.59 | 15.86% | 2.58% | 10.55% | -19.05% | |
61 Neutral | £585.89M | 16.91 | 13.04% | 3.18% | 4.29% | 7.68% | |
54 Neutral | £339.53M | 261.22 | 0.58% | 2.31% | 10.68% | -89.58% | |
45 Neutral | £366.52M | -2.21 | -142.88% | ― | -7.30% | -311.68% | |
42 Neutral | £1.74B | 134.24 | -5.79% | 0.36% | -2.90% | -2.16% |